Add to ORKGA retrospective study of the incidence of rheumatoid arthritis and systemic malignancy was performed using the records of 196 older age patients with classic or definite rheumatoid arthritis. The results were compared to 125 patients in the same age group who had arthritis of a non-rheumatoid type. There was no difference in the incidence of malignancy in the two groups of patients. However, there was a positive correlation between the incidence of malignancy and the use of long term adrenocorticosteroid therapy
OBJECTIVE: To compare the incidence rates of malignancy among patients with psoriatic arthritis (PsA...
Objective: Psoriatic arthritis (PsA) is an inflammatory arthropathy, associated with skin and/or nai...
Background: Early diagnosis is the key to successful treatment of inflammatory rheumatic diseases an...
Inhibitors of tumor necrosing factor alpha (TNF-a) have proven to be highly effective in the treatme...
Relatively sparse literature developed during the past 30 years that sought to characterize the rela...
Background: A number of rheumatic disorders are associated with an increased risk for various malign...
Background Rheumatoid arthritis (RA) is a chronic, inflammatory disease with joint destruction and p...
Objective: An increased risk for certain types of malignancies has been reported in rheumatoid arthr...
International audienceObjective To compare the risk of malignancy between patients with rheumatoid a...
Introduction Rheumatic diseases (RDs) are associated with different cancers; howeve...
OBJECTIVE: Because of concerns about malignancy risks, using biological disease-modifying antirheuma...
A patient population admitted to the hospital for either SLE or RA was surveyed for the subsequent d...
Objective. To explore the influence of TNF inhibitor (TNFi) therapy and rituximab (RTX) upon the inc...
SUMMARY A consecutive series of 489 patients with rheumatoid arthritis seen at the centre was studie...
Although scientifically unproven, general empirical agreement supports the notion that the early det...
OBJECTIVE: To compare the incidence rates of malignancy among patients with psoriatic arthritis (PsA...
Objective: Psoriatic arthritis (PsA) is an inflammatory arthropathy, associated with skin and/or nai...
Background: Early diagnosis is the key to successful treatment of inflammatory rheumatic diseases an...
Inhibitors of tumor necrosing factor alpha (TNF-a) have proven to be highly effective in the treatme...
Relatively sparse literature developed during the past 30 years that sought to characterize the rela...
Background: A number of rheumatic disorders are associated with an increased risk for various malign...
Background Rheumatoid arthritis (RA) is a chronic, inflammatory disease with joint destruction and p...
Objective: An increased risk for certain types of malignancies has been reported in rheumatoid arthr...
International audienceObjective To compare the risk of malignancy between patients with rheumatoid a...
Introduction Rheumatic diseases (RDs) are associated with different cancers; howeve...
OBJECTIVE: Because of concerns about malignancy risks, using biological disease-modifying antirheuma...
A patient population admitted to the hospital for either SLE or RA was surveyed for the subsequent d...
Objective. To explore the influence of TNF inhibitor (TNFi) therapy and rituximab (RTX) upon the inc...
SUMMARY A consecutive series of 489 patients with rheumatoid arthritis seen at the centre was studie...
Although scientifically unproven, general empirical agreement supports the notion that the early det...
OBJECTIVE: To compare the incidence rates of malignancy among patients with psoriatic arthritis (PsA...
Objective: Psoriatic arthritis (PsA) is an inflammatory arthropathy, associated with skin and/or nai...
Background: Early diagnosis is the key to successful treatment of inflammatory rheumatic diseases an...